Newtyn Management LLC decreased its position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) by 26.9% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 500,000 shares of the company’s stock after selling 183,648 shares during the quarter. Phathom Pharmaceuticals makes up 1.3% of Newtyn […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) shot up 9.4% during trading on Tuesday . The company traded as high as $10.65 and last traded at $10.16. 351,678 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 761,808 shares. The stock had previously closed at $9.29. Analyst […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s share price was up 9.4% on Tuesday . The company traded as high as $10.65 and last traded at $10.16. Approximately 351,678 shares traded hands during mid-day trading, a decline of 54% from the average daily volume of 761,808 shares. The stock had previously closed at $9.29. […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) saw a large growth in short interest during the month of January. As of January 15th, there was short interest totalling 8,190,000 shares, a growth of 15.7% from the December 31st total of 7,080,000 shares. Approximately 30.8% of the company’s stock are short sold. Based on an […]
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report) was the recipient of a large growth in short interest in January. As of January 15th, there was short interest totalling 8,190,000 shares, a growth of 15.7% from the December 31st total of 7,080,000 shares. Based on an average trading volume of 573,600 shares, the short-interest ratio […]